We are live on ! Find out more
TLOG

TetraLogic Pharmaceuticals Corporation
TLOG

Delisted

TLOG was delisted on the 3rd of November, 2016.

29 hedge funds and large institutions have $11.5M invested in TetraLogic Pharmaceuticals Corporation in 2015 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 3

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

12% less funds holding

Funds holding: 3329 (-4)

22% less capital invested

Capital invested by funds: $14.7M → $11.5M (-$3.24M)

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

Holders
29
Holders Change
-4
Holders Change %
-12.12%
% of All Funds
0.81%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
4
Increased
7
Reduced
3
Closed
8
Calls
Puts
Net Calls
Net Calls Change

TLOG Hedge Fund Activity: Q3 2015 in Review

29 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in TetraLogic Pharmaceuticals Corporation (TLOG) for Q3 2015, worth a combined $11.5M — down 22% from $14.7M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of TLOG and 4 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 7 added.

The largest buyer was Bank of New York Mellon, adding an estimated $257K. The largest seller was Lazard Asset Management, exiting entirely with an estimated $211K sold.

  • 29 institutional investors held TetraLogic Pharmaceuticals Corporation (TLOG) as of Q3 2015, down from 33 in Q2 2015.
  • Funds reported $11.5M of TetraLogic Pharmaceuticals Corporation stock for Q3 2015, down 22% quarter-over-quarter.
  • 4 funds opened new TetraLogic Pharmaceuticals Corporation positions in Q3 2015 and 8 closed out, a net change of -4 holders.
  • The largest TetraLogic Pharmaceuticals Corporation buyer in Q3 2015 was Bank of New York Mellon, an estimated $257K added.
  • The largest TetraLogic Pharmaceuticals Corporation seller in Q3 2015 was Lazard Asset Management, an estimated $211K sold.

Based on aggregated 13F filings for Q3 2015.